Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
DOJ
An FCA Journey – Allergan to Pay $53M to DOJ
Allergan has been hit with hefty fines over the past several months. This article outlines Allergan's alleged wrongdoing, and the…
Quest to Pay $6 Million to Settle Kickback and Unnecessary Testing…
On April 28, 2017, the United States Department of Justice announced a settlement with Quest Diagnostics, Inc., for $6 million to…
Novo Nordisk Settles Qui Tam Suit
Novo Nordisk is in the midst of settling a whistleblower lawsuit that alleges that the company ran a “white-coat marketing scheme”…
Mylan Settlement Classified as “Too Low”
Many of our readers may remember back in October 2016, when Mylan agreed to pay $465 million to settle claims related to the way…
DOJ Has Third Highest Annual Recovery in FCA History
The United States Department of Justice has announced the fiscal year 2016 recoveries from civil False Claims Act. This…
Bristol-Myers Squibb Settles Off-Label Promotion Case for $19.5 Million
Late last year, Bristol-Myers Squibb (BMS) settled with the government to resolve allegations that spanned several states that it…
Sanofi Settles Vaccine Antitrust Dispute
Sanofi Pasteur Inc., has agreed to pay $61.5 million in a five-year long class action brought by doctors alleging that the drug…
Former Tenet Healthcare Executive Charged
John Holland, former senior executive of Tenet Healthcare Corporation, was recently indicted for his alleged role in a $400…
Department of Justice Increases FCA Civil Penalties, Again
On February 3, 2017, the Department of Justice (DOJ) announced that False Claims Act (FCA) penalties will once again be…
Zimmer Biomet Pays $30 Million to Resolve New FCPA Charges
Medical device maker Zimmer Biomet Holdings, Inc., agreed to pay $30.5 million to resolve Department of Justice (DOJ) and…